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A 16-base-pair insertion has been identified as the mutation responsible for the
high-copy-number phenotype of the plasmid copy number mutant pFH118. The
mutation is located near the plasmid origin of replication in a region of the genome
that encodes two overlapping RNA transcripts. One of these transcripts, RNA I,
acts as a negative regulator of plasmid replication. The second transcript is the
precursor to the primer for the initiation of DNA synthesis. We demonstrate
through complementation that the pFH118 DNA overproduction phenotype is a
consequence of the reduced effectiveness of the mutant RNA I at inhibiting
plasmid replication and not a consequence of an altered target site on the primer
precursor. In addition, a series of plasmids containing multiple RNA I-coding
genes was constructed for investigating the effects of RNA I gene dosage on
plasmid copy number and incompatibility. The results of this study strongly
support the inhibitor dilution model of plasmid copy control with RNA I as the
plasmid-specified inhibitor responsible for both copy number control and incom-
patibility.
The stable inheritance of multicopy bacterial
plasmids at defined copy numbers implies a
mechanism that strictly regulates the number of
plasmid replication events within each cell divi-
sion cycle. The inhibitor dilution model (19, 20)
proposes that initiation of plasmid DNA replica-
tion is repressed by a plasmid-specified, trans-
acting element, whose cellular concentration
reflects the concentration of plasmids in the cell.
Plasmid replication increases the number of
plasmid molecules and the number of active
inhibitor genes inside the cell. When a "critical"
level of inhibitor is obtained, initiation of plas-
mid DNA synthesis is completely repressed.
During growth and division of the cell, the
inhibitor is diluted below the critical concentra-
tion, permitting new initiation of plasmid DNA
synthesis.
For the amplifiable plasmids containing the
replicons of ColEl, pMB1, NTP1, p15A, or
CloDF13, there is accumulating evidence that a
small, replicon-specified transcript, RNA I,
functions as the primary inhibitor of plasmid
DNA replication (6, 18, 25, 26). We previously
proposed the involvement of RNA I in plasmid
copy number control from our observation that
the insertion mutation responsible for the mu-
tant high-copy phenotype of the pMB1-derived
plasmid, pFH118, lies within the coding region
for this small transcript (6). Spontaneous rever-
tants of pFH118, displaying the wild-type copy
number, were found to have deleted the inser-
tion sequence and produced a normal RNA I.
Tomizawa et al. (26) later demonstrated that
purified RNA I inhibits initiation of plasmid
DNA synthesis in vitro by preventing the proc-
essing of a second plasmid transcript to form an
RNA primer for DNA polymerase I. The primer
precursor is initiated about 550 nucleotides up-
stream from the origin of DNA synthesis and
terminates downstream of the origin (13). Proc-
essing of this transcript involves RNase H, an
endonuclease which preferentially degrades
RNA in RNA-DNA hybrids. RNA I, through an
undefined mechanism, interacts with the primer
precursor during its transcription to prevent the
transcript from forming a stable RNA-DNA hy-
brid with its template near the replication origin
(14, 25).
RNA I and the primer precursor are both
transcribed from the same region of the plasmid
genome, but from opposite DNA strands (13).
One consequence of the transcripts' overlap is
that the entire RNA I nucleotide sequence is
complementary to the 5' end of the primer
precursor. The RNA I molecule has a high
degree of internal sequence symmetry (17) and
may, under normal physiological conditions,
adopt a tRNA-like structure with three partially
double-stranded regions and three single-strand-
ed loops (designated by Roman numerals I, II,
and III in Fig. lb). The active sites of the RNA I
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FIG. 1. (a) Representative sequencing gel of the RNA I-coding region of the copy number mutant pFH118.
Sequencing was done by the method ofMaxam and Gilbert (16). Details are provided in the text. The nucleotides
bracketed by arrows are the additional nucleotides introduced into RSF1050 during mutagenesis. (b) Nucleotide
sequence ofRNA I from pFH118 as deduced from ourDNA sequences. The secondary structure of the wild-type
RNA shown is that proposed by Morita and Oka (17). The location of the insertion in pFH118 is indicated by the
arrow, and the sequence of the additional nucleotides is presented in brackets. With the exception of this
insertion, the nucleotide sequence of this region was found to be identical to that of pBR322 and pMB9, also
derivatives of pMB1, and to differ from that of ColEl at one position (24, 25).
molecule, like the active site of the tRNA, are
considered to lie within one or more of the
single-stranded loops (9, 14, 25). A similar stem-
and-loop structure can also be predicted for the
region of the primer precursor complementary
to RNA I. From characterizations of inhibitor
target mutants of pMB1, Lacatena and Cesareni
(14) conclude that the secondary structure of
this region of the primer precursor is required
for successful inhibitory interaction. Sequence
analysis of these mutants reveals the importance
of the central loop (loop II) in the mechanism for
plasmid copy number control.
In this paper we present results of comple-
mentation experiments with a high-copy-number
mutant of pMB1 from which we conclude that
loop structure III of RNA I is required for the
transcript's inhibitory function. A 16-nucleotide
insertion within the stem of this structure se-
verely reduces the effectiveness of the transcript
as a repressor of plasmid replication. The ho-
mologous insertion within the primer precursor
does not appear to inactivate the target of inhibi-
tion. We also present evidence of a "critical"
concentration of RNA I (as deduced from gene
dosage) for complete repression of plasmid repli-
b
111
:
.L£- .&
*8.w.
:::!:
J. BACTERIOL.
REGULATION OF PLASMID DNA REPLICATION 811
-550 -446
RNA- I Wo
PRIMER RNA A&*4wwAwv
ORI DIRECTION OF
&.1:7- REPLICATION-
FnuDII Hhnf FnuDII RSFlO50
-569 -313 +13 Fnu DI-D Fragment
End-filling reaction (DNA polymeraseI-large fragment)
Ligation of BamHI linkers (T4 Ilgase)
Barm Hi digestion
Or.t a.-M lI run, untnin;iA ts odming raqmeniconteiningRNA- I coding sequence
T4 Ligose
B B B B fB
B ~~~~~~~BB
R I RI RI RI RI
RI RI pDM251 pDM252 pDM253
pDM 246 pDM 247
BB
RI
pDM 254
FIG. 2. Construction of plasmids. The 582-bp FnuDII-D fragment of RSF1O05 was cleaved with Hinfl to yield
two fragments. The Hinfl ends of the fragments were made blunt ended by repair with DNA polymerase I.
BamHI ends were generated by attachment ofBamHI linkers followed by digestion with BamHI endonuclease.
The DNA fragments were separated from the unattached linkers by Bio-Gel A-Sm (Bio-Rad Laboratories)
chromatography and then ligated with BamHI-digested pFH118. The ligation mixture was used to transform E.
coli HB101. Ampicillin-resistant transformants were screened by restriction enzyme analysis of plasmid DNA
from minilysates. Recombinant plasmids containing one and two 263-bp BamHI inserts were isolated and
designated pDM246 and pDM247, respectively. Purified inserts from BamHI-digested pDM247 DNA were
partially polymerized by allowing the inserts to self-ligate in the presence of T4 ligase. BamHI-cut pACYC184
was then added, and ligation was continued. After transformation and screening of chloramphenicol-resistant,
tetracycline-sensitive colonies, clones containing pACYC184 derivatives with one, two, three, and four BamHI
inserts were isolated. These plasmids were designated pDM251 through pDM254, respectively.
cation as postulated in the inhibitor dilution
model. Finally, we present results which direct-
ly link plasmid copy-number control and incom-
patibility.
MATERIALS AND METHODS
Materials. BamHI linkers (octamers) were obtained
from Collaborative Research, Inc. Restriction en-
zymes were purchased from New England Biolabs.
Escherichia coli DNA polymerase I (large fragment)
was obtained from Boehringer Mannheim. Phage T4
polynucleotide ligase and kinase and E. coli RNA
polymerase holoenzyme were gifts from Charles C.
Richardson. [a-32P]UTP (25 Ci/mmol) was from ICN
Pharmaceuticals Inc.
Bacterial strains and plasmids. Experiments were
carried out in E. coli HB101 pro gal hsdR hsdM recAL.
Plasmid RSF1050 and its high-copy-number deriva-
tive, pFH118, have been described previously (12).
Plasmid pACYC184 is a tetracycline- and chloram-
phenicol-resistant derivative of the cryptic miniplas-
mid pl5A (3). Other plasmids used in these studies are
described in Fig. 2 and Table 1.
Preparation of plasnid DNA. A modification of the
method of Clewell and Helinski (4) was used to
prepare plasmid DNAs and has been described previ-
ously in detail (5).
Agarose gel electrophoresis. Conditions for agarose
gel electrophoresis have been previously described
(7).
DNA sequencing. The 580-base-pair (bp) FnuDII
restriction fragment containing the origin region of
RSF1050 (Fig. 2) was isolated from an acrylamide gel
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TABLE 1. Plasmids used in this study
No. of copiesa RelativePlasmid Replication origin pMB1 RNA I-wt pMB1 RNA 1-mut copy no.
RSF1050 RS1050 (wild type) 1 1
pFH118 pFH118 (mutant) 1 12
pDM246 pFH118 1 1 0.4
pDM247 pFH118 2 1 0.2
pDM248 pFH118 2 2.3
pACYC184 pACYC184 0.3
pDM251 pACYC184 1 0.3
pDM252 pACYC184 2 0.3
pDM253 pACYC184 3 0.3
pDM254 pACYC184 4 0.3
a The copy number of each plasmid was normalized to the amount of RSF1050, which was given a value of 1.
and labeled at the 5' ends with T4 polynucleotide
kinase and [y32P]ATP (21). This fragment was then
cleaved with HaeIII, generating a 430-bp fragment and
a 150-bp fragment containing the RNA I-coding se-
quences. The nucleotide sequence of the 150-bp frag-
ment was determined by the method of Maxam and
Gilbert (16).
In vitro RNA synthesis. Covalently closed, circular
plasmid DNA was transcribed by using purified E. coli
RNA polymerase holoenzyme in a reaction mixture
(0.1 ml) containing 50 mM Tris-hydrochloride (pH
7.9), 0.1 M KCI, 8 mM MgCl2, 1 mM dithiothreitol, 10
,ug of yeast tRNA per ml, 40 ,uM each of four ribonu-
cleotide triphosphates (including [a-32P]UTP), 5 U of
RNA polymerane per ml, and 10 ,ug of plasmid DNA
per ml. Incubation was at 37°C for 30 min. The
reaction was terminated by addition of 5 p.l of 250 mM
EDTA. After precipitation with ethanol, transcription
products were separated by electrophoresis in a dena-
turing polyacrylanmide gel containing 7 M urea (15).
RESULTS
Nucleotide sequence of the copy number muta-
tion in pF}H1I8. The plasmid RSF1050 is a 5.0 x
106-dalton, ampicilin-resistant derivative of the
plasmid pMB8 into which Tn3 has been trans-
posed (10). pMB8 is a miniderivative of the
naturally occuring plasmid pBM1, which is
closely related to, but not identical with, ColEl
(1, 22). The high-copy-number mutant plasmid
pFH118 was generated from RSF1050 by a tech-
nique that employs synthetic oligonucleotide
EcoRI linkers as mutagens (12). The mutant
plasmid contains a new EcoRI site at the site of
linker insertion. In pFH118 this site is located
about 520 bp upstream (5' to the direction of
replication) from the origin of replication in the
coding region for the RNA I transcript (6).
To determine the exact location of the linker
insertion in pFH118, the nucleotide sequence of
the RNA I-coding region was determined. A
representative sequencing pattern and sequence
of RNA I as deduced from the DNA sequence
we have determined is shown in Fig. 1. The
EcoRI octamer used to construct the mutant is
inserted 57 bp from the RNA termination site. In
addition, eight base pairs 5' to this insertion are
repeated on the 3' side, making the total size of
the insertion 16 bp. This repeat was probably
generated from the in vitro mutagenesis proce-
dure, in which linear plasmids with single-
stranded ends are repaired with DNA polymer-
ase I before the addition of EcoRI linkers.
Similar structures have been reported among
Tn3 mutants prepared by this procedure (11). In
vitro transcription of pFH118 in the presence of
RNase H reveals that both RNA I and the
primer RNA are 16 nucleotides longer than the
corresponding transcripts from RSF1050 (data
not shown). The 16 additional nucleotides fall
within stem III of the proposed secondary struc-
tures ofRNA I and its complementary region in
the primer precursor.
Characterization of the pFH118 mutation: com-
plementation by the wild-type RNA I. Since the
mutation in pFH118 falls within the region of the
plasmid that encodes the inhibitor RNA I and
also the target site of RNA I inhibition on the
primer precursor, the plasmid's high-copy-num-
ber phenotype could be attributed to either a
defective inhibitor or a modified target site that
is no longer recognized by the inhibitor or both.
In the first case, the addition of wild-type RNA I
should result in the complementation of the
high-copy-number mutation. We decided to in-
vestigate this possibility by inserting the wild-
type RNA I coding sequence into a nonessential
region of the copy number mutant pFH118. To
avoid ambiguities related to copy number effects
mediated by plasmid regulatory elements other
than RNA I, such as that identified by Twigg and
Sherratt (27), we used a small restriction frag-
ment which contains little more than the essen-
tial nucleotide information for transcription
of the complete wild-type RNA I. A 256-bp
FnuDII-Hinfl restriction fragment from
RSF1050 contains the complete wild-type RNA
I-coding sequence plus 21 bp of DNA 3' to the
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FIG. 3. In vitro synthesis of RNA I. Supercoiled plasmid DNA was transcribed in vitro as described in the
text. 32P-labeled transcripts were separated on either a 6% (a) or 8% (b) polyacrylamide gel (19:1 acrylamide/bis-
acrylamide ratio) containing 7 M urea. Gels were dried and autoradiographed as described previously (7).
Plasmids transcribed were as follows: in a, (1) RSF1OS0, (2) pFH118, (3) pDM246, (4) pDM247; in b, (1)
RSF1050, (2) pACYC184, (3) pDM251, (4) pDM252, (5) pDM253, (6) pDM254.
RNA I termination site and 130 bp ofDNA 5' to
the transcript's initiation site, which includes the
entire recognition sequence for RNA polymer-
ase (Fig. 2 and Table 1). The fragment was
inserted, by using BamHI linkers, into the single
BamHI restriction site of pFH118, approximate-
ly 2.7 kb from the site of the copy number
mutation. The recombinant plasmid, pDM246,
when transcribed in vitro, produces two distinct
RNA I transcript bands of approximately equal
intensity which comigrate on a denaturing acryl-
amide gel with the RNA I transcripts of pFH118
(RNA I-mut) and RSF1050 (RNA I-wt) (Fig. 3a).
A second recombinant which had picked up two
BamHI inserts was also isolated from cells
transformed with the same ligation mixture. In
vitro transcription of this plasmid, pDM247,
yields both RNA I-wt and RNA 1-mut tran-
scripts at a ratio of approximately 2:1 (Fig. 3a).
To test whether the wild-type RNA I transcribed
from these plasmids complemented the high-
copy-number mutation, we determined plasmid
copy numbers.
Plasmid copy numbers were first examined in
a general way from the relative resistances of
plasmid-containing cells to ampicillin and then in
a more quantitative way by direct analysis of
plasmid DNA from cell lysates on agarose gels.
Uhlin and Nordstrum (28) have shown for Rl
plasmid derivatives that single cell resistance to
ampicillin in agar plates is proportional to 3-
lactamase gene dosage. In Fig. 4, we compare
ampicillin resistances of E. coli HB101 contain-
ing various plasmids. Bacterial cells which carry
the high-copy-number mutant pFH118 are rela-
tively insensitive to high levels of ampicillin up
to 1,000 ,ug/ml, whereas bacteria carrying the
homologous wild-type plasmid, RSF1050, are
unable to grow at this drug concentration. Cells
containing pDM246 are much more sensitive to
lower ampicillin concentrations than is pFH118.
This result suggests that the presence of the
RNA I-wt gene complements the mutation in
this plasmid, that is, that RNA I-wt binds better
than RNA I mut to the pFH118 target. Cells
containing plasmid pDM247 were the most sen-
sitive to ampicillin, indicating that when two
RNA I-wt genes are present, plasmid copy num-
ber is reduced even more. As a control, the
RNA I-mut gene was isolated from pFH118 and
inserted into the pFH118 BamHI site. This plas-
mid, pDM248, is identical to pDM246, except
that it carries the 16-bp insertion mutation within
the cloned RNA I gene. Cells carrying pDM248,
like cells carrying the high-copy number mutant
pFH118, grow well on plates containing 1,000 jig
of ampicillin per ml.
To confirm that plasmid copy number effects
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FIG. 4. Ampicillin resistance of various plasmid-
containing cells. E. coli HB101 organisms containing
indicated plasmids were taken from 5-ml overnight
cultures in L broth supplemented with 0.2% glucose
and spread onto L plates containing 0.2% glucose and
various amounts of ampicillin. Visible colonies were
counted after an 18-h incubation at 37°C. Relative
survival is determined as a percentage of the colonies
growing on plates without ampicillin.
were responsible for the observed differences in
cellular resistance to ampicillin, quantitative de-
terminations of plasmid copy number were made
from electrophoretic analysis of plasmid DNA
from cell lysates as described in the legend to
Fig. 5. The plasmid copy numbers obtained with
this procedure correlate well with the relative
ampicillin resistances of cells containing these
plasmids. These results are summarized in Table
1 and indicate that (i) the copy number of
pFH118, as a result of the 16-bp insertion muta-
tion within the RNA I coding region, is 12-fold
higher than that of the homologous wild-type
plasmid RSF1050; (ii) insertion of a 256-bp re-
striction fragment encoding the wild-type RNA I
into pFH118 (pDM246) results in a 30-fold re-
duction of the plasmid copy number; (iii) inser-
tion of a second RNA I-wt gene into this plasmid
gives a further twofold copy number reduction
(pDM247). In contrast, insertion of the mutant
RNA I gene into the pFH118 BamHI site gives
only a fivefold reduction of copy number
(pDM248). The copy number of plasmid
pDM248 is still more than two times greater than
that of the wild-type plasmid, RSF1050. From
these observations we conclude that the plasmid
overproduction phenotype of pFH118 results
from the inability of RNA 1-mut to effectively
inhibit plasmid DNA replication. The mutant
RNA I, however, is not completely ineffective
as an inhibitor of replication (compare copy
numbers of plasmids pFH118 and pDM248 con-
taining one and two RNA I genes, respectively).
The reduced effectiveness of this transcript in
repressing initiation of plasmid DNA synthesis
probably results from the disruption of the sec-
ondary structure of the RNA molecule by the 16
...i . . . .
FIG. 5. Plasmid copy number comparison. E. coli
HB101 cells containing plasmids RSF1050, pFH118,
pDM246, pDM247, or pDM248 were grown in 150 ml
of L broth containing 0.2% glucose and 25 jig of
ampicillin per ml to an optical density at 550 nm
between 0.6 and 0.9 and quickly chilled on ice. After
dilution of the cultures to an optical density 0.6, 150 ml
of each culture was mixed with an equal volume of a
similarly diluted culture of HB101 cells containing the
plasmid pACYC184. The addition of the pACYC184-
containing cells was to provide an interal standard for
monitoring the recovery of plasmid DNA after cell
lysis. Cleared cell lysates were then prepared by the
procedure of Clewell and Helinski (4), and supercoiled
plasmid DNAs were isolated by equilibrium centrifu-
gation in cesium chloride-ethidium bromide density
gradients. The plasmid DNAs were then analyzed by
electrophoresis through a 0.9% agarose gel. The lower
band in each lane contains the supercoiled form of
pACYC184. The upper bands contain the supercoiled
forms of the pMBl-derived plasmids. The relative
amounts of plasmid DNA were quantitated by densi-
tometry. A photographic negative of another gel (not
shown) containing different dilutions of these samples
was scanned to ensure that comparative measure-
ments of band densities were done within the linear
range of the densitometer. Areas under the densitome-
try peaks were integrated with the aid of a Tektronix
4965 digitizing tablet interfaced to a Tektronix 4052
computer. By using the previously reported value of
18 for the minimal copy number of pACYC184 in
HB1o1, the minimal copy numbers of the pMB1 plas-
mids were calculated to be as follows: RSF1050, 60;
pFH118, 720; pDM246, 24; pDM247, 12; pDM248,
140.
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additional nucleotides in stem III. Complemen-
tation of the pFH118 mutation by the wild-type
RNA I indicates that the target of inhibition is
not severely altered by the 16-nucleotide inser-
tion within the primer precursor. This implies
that stem structure III of the primer precursor is
not of primary importance for this mechanism of
copy number control.
RNA I and incompatibility. Two closely relat-
ed plasmids are said to be incompatible if they
are unable to stably coexist within the same
bacterial cells growing under nonselective con-
ditions. As cells which originally carry two
incompatible plasmids divide, either one of the
plasmids will be lost from the cell population or
else the cells may segregate into two popula-
tions, each containing only one of the two plas-
mids. According to the inhibitor dilution model,
incompatibility arises as a consequence of the
inability of the plasmid-specified inhibitors to
distinguish their respective replicons (20). Tom-
izawa and Itoh (25) have isolated several
ColEl mutants with altered incompatibility
properties. These incompatibility mutants con-
tain single-base-pair changes within the RNA I
coding sequence. In vitro transcription experi-
ments demonstrate that the single-base-pair
changes affect both the ability of RNA I to
inhibit primer formation and the sensitivity of
primer formation to inhibition by RNA I. Each
of the incompatibility mutants they examined
was also a high-copy-number mutant, implicat-
ing RNA I as the plasmid-specified element
involved in both copy number control and in-
compatibility.
We decided to further investigate incompati-
bility effects due to RNA I inhibition by inserting
the pMB1 RNA I gene into a plasmid compatible
with pMB1. The RNA I coding region from the
pMB1-derived plasmid, RSF1050, was ligated
into the single BamHI restriction site of
pACYC184 (Fig. 2). Plasmid pACYC184 con-
tains the replicon from plSA and is compatible
with ColE1-pMB1-derived plasmids (3). To
compare the effects of RNA I gene dosage on
incompatibility, four recombinant plasmids were
constructed which contain from one to four
identical pMB1-RNA I genes inserted into the
pACYC184 BamHI site. The chimeric plasmids,
pDM251 through pDM254, each code for the
transcription of two distinct species of RNA I
(Fig. 3b). The slightly longer RNA I is identical
to that transcribed from RSF1050. The smaller
RNA I is transcribed from pACYC184.
We first examined the effects of the chimeric
plasmids on the high-copy-number mutant
pFH118. We attempted to prepare doubly trans-
formed cells by introducing pFH118 by transfor-
mation into E. coli HB101 carrying pACYC184
or one of the chimeric plasmids, pDM251
through pDM254, and selecting on L agar plates
containing chloramphenicol (25 ,ug/ml) and am-
picillin (50 or 1,000 ,ug/ml). The results of this
transformation are presented in Table 2. Cells
containing pACYC184 were efficiently trans-
formed to resistance to 50 ,ug of ampicillin per ml
with pFH118. These double transformants also
grew well on plates containing 1,000 ,ug of
ampicillin per ml, indicating that pFH118 was
present at high copy number. In contrast, trans-
formation frequencies (from plates with 50 Rg of
ampicillin per ml) of cells containing any of the
chimeric plasmids were appreciably lower and
decreased with each additional pMB1 RNA I
gene carried by the resident plasmid. With three
or four of these genes present, no transformants
with pFH118 could be obtained. If the resident
plasmid contained only one or two of these
genes, transformants with pFH118 could be iso-
lated from plates with 50 ,ug of ampicillin per ml,
but not from plates with 1,000 ,g of ampicillin
per ml, indicating that the copy number of
pFH118 is reduced in these cells.
These results indicate that the pFH118 high-
copy-number mutation is complemented by the
pMB1 species ofRNA I. In addition, we observe
a correlation between the number of RNA I
genes carried by the resident plasmid and the
transformation frequency with pFH118 as the
incoming plasmid. The most striking aspect of
these results is the failure of pFH118 to become
established in cells where there are more than
two pMB1 RNA I genes on the resident plasmid.
We interpret these results as indicating that the
elevated level ofRNA I in these cells at the time
TABLE 2. Transformation of various plasmid-
carrying strains with pFH118 (Ap)a
Transformants per ,ug ofNo. of pFH118 DNA appearing
Resident plasmid RNAM on plates containing
coNAng ampicillincoding
regions 50 1,000
p,g/ml ,ug/ml
pACYC184 (Cm, Tc) 0 1.1 x 106 8.7 x 105
pDM251 (Cm) 1 6.0 x 105 <103
pDM252 (Cm) 2 2.0 x 105 <l03
pDM253 (Cm) 3 <103 <103
pDM254 (Cm) 4 <103 <103
a HB101 cells carrying the indicated plasmids were
transformed with 20 ng of pFH118 after a standard
transformation procedure (8). Each transformation
mixture was added to 2 ml of L broth and incubated at
37°C for 2 h before plating only L agar plates contain-
ing 0.2% glucose and the antibiotics chloramphenical
(25 ,ug/ml) and ampicillin (50 ,ug/ml). After incubation
for 18 h at 37°C the visible colonies were counted. A
transformation frequency of <103/,ug means that no
transformants were observed.
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TABLE 3. Exclusion of pFH118 and RSF105O from
cells after the establishment of a second plasmid
encoding pMB1 RNA Ia
No. of Fraction of total cells af-
Incoming RNA I ter 6 generations exhibit-
plasmid genes ing ampicillin resistance
perpersfid pFH118 RSF1050
pACYC184 0 1.0 1.0
pDM251 1 1.0 1.0
pDM252 2 0.8 1.0
pDM253 3 <10-3 <0-3
pDM254 4 <10-3 <10-3
a The plasmids indicated were used to transform E.
coli HB101 carrying either pFH118 or RSF1050. Colo-
nies which grew up on agar-plates containing both
ampicillin (50 ,ug/ml) and chloramphenicol (25 ,ug/ml)
were used to prepare cultures of cells growing in L
broth supplemented with 0.2% glucose. After approxi-
mately six generations of growth at 370C under nonse-
lective conditions, samples of the cultures were spread
onto L plates and L plates containing ampicillin (50 ,g/
ml). After overnight incubation of the plates at 370C
the colonies were counted, and the ratio of ampicillin-
resistant cells to total cells was determined.
of pFH118 introduction completely inhibits rep-
lication of the incoming plasmid, thus preventing
its establishment. In agreement with this inter-
pretation we found that doubly transformed cells
of pFH118 and each of the chimeras could be
prepared by beginning with cells containing
pFH118 and then introducing one of the chime-
ras by transformation. All of the doubly trans-
formed cells prepared in this manner could be
selected initially on plates containing chloram-
phenicol and 1,000 ,ug of ampicillin per ml.
Colonies from these plates were used to con-
duct a segregation test (Table 3). After six
generations of growth in L broth in the absence
of selective drugs, bacteria were spread onto L
plates without drugs and L plates containing 50jxg of ampicillin per ml. We found that pFH118
was not excluded from the cells which also
carried pACYC184 or the chimeras containing
one or two pMB1 RNA I genes. However,
pFH118 was rapidly lost from cells carrying the
chimeras with three or four pMB1 RNA I genes.
When segregaton tests were conducted with
RSF1050 instead of pFH118, similar results
were obtained, with RSF1050 being rapidly ex-
cluded only by pDM253 and pDM254.
These results can be explained according to
the inhibitor dilution model. Since the plSA
replicon of pACYC184 is not inhibited by the
pMB1 RNA I species (26), the copy numbers of
plasmids pDM251 through pDM254 are approxi-
mately equal to the copy number of pACYC184
(data not shown). We have observed that
pACYC184 is maintained at a copy number that
is approximately one-third that of the pMB1-
derived plasmid, RSF1050 (Fig. 5). If the cellular
concentration of RNA I is proportional to the
number of RNA I genes, as postulated by the
inhibitor dilution model, then the pMB1 RNA I
concentration in cells containing the chimeric
plasmids will be lower than the critical inhibitory
concentration unless there are at least three
copies of the gene transcribing this RNA per
pACYC184 vector. The abrupt change in com-
patibility properties that we observe in going
from two to three pMB1 RNA I genes per vector
probably results from the increase in cellular
RNA I concentration to a level exceeding the
critical inhibitory concentration.
DISCUSSION
Perhaps the most powerful technique for in-
vestigating the molecular mechanisms responsi-
ble for the regulation ofDNA synthesis in E. coli
is the generation and characterization of plasmid
copy number mutants. In this paper we extend
our previous studies on the high-copy-number
mutant pFH118 by identifying the mutation as a
16-bp insertion within the region of the plasmid
genome which codes for the transcription of
RNA I and the primer precursor. The mutation
disrupts nucleotide pairing within the stem of
one of three loop structures in the proposed
secondary structure for both RNA I and the 5'
end of the primer precursor. We demonstrate
through complementation studies that the muta-
tion in pFH118 affects the ability of RNA I to
inhibit plasmid replication without noticeably
affecting the sensitivity of the plasmid to inhibi-
tion by wild-type RNA I. The pFH118 high-
copy-number phenotype is suppressed when a
256-bp DNA fragment that codes for the tran-
scription of the wild-type RNA I is cloned
directly into pFH118 or into a second, unrelated
plasmid within the same cell. The location of the
mutation within the stem of the loop structure
III (Fig. 1) suggests that this structure is critical
for the inhibitory function of RNA I, but is not
essential within the primer precursor for target
site recognition. Lacatena and Cesareni (14)
characterized dominant target mutations that
were not complemented by wild-type RNA I.
Their results demonstrated the importance of
the central loop (loop II) in both RNA I and the
primer precursor for successful inhibition. They
have also found a dominant target mutation
within the stem of loop I. Muesing et al. (18)
have reported a copy number mutant of ColEl
that contains a single base-pair alteration within
the stem of loop III. This mutation, like the
mutation in pFH118, can be complemented in
trans by the wild-type plasmid (23).
According to the inhibitor dilution model,
plasmid copy number is regulated through a
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mechanism offeedback inhibition. Plasmid repli-
cation increases the number of plasmids per cell,
which in turn increases the concentration of the
plasmid-specified inhibitor. Plasmid replication
ceases when the level of the inhibitor reaches a
"critical" level for the complete repression of
initiation of plasmid DNA synthesis. One would
predict from this model that if the number of
inhibitor molecules produced from each plasmid
molecule were doubled, the stable copy number
of the plasmid would be reduced to half of its
original value. In agreement with this prediction
and with the evidence implicating RNA I as the
plasmid-specified inhibitor of replication, we
have observed that plasmid pDM247, which
contains two identical wild-type RNA I genes,
has a copy number which is one-half that of
plasmid pDM246, which contains only a single
wild-type RNA I gene.
We have also presented evidence directly
linking RNA I inhibition to the phenomena of
plasmid incompatibility, a finding previously re-
ported by Tomizawa and Itoh (25). The plasmid
pACYC184, which is normally compatible with
the pMB1-derived plasmid, RSF1050, and its
copy number mutant, pFH118, exhibits severe
incompatibility toward these plasmids when
more than two pMB1 RNA I genes are inserted
into the plasmid's single BamHI site. The rapid
exclusion of RSF1050 and pFH118 from cells
containing either pDM253 or pDM254 implies
that the former pMB1-derived plasmids are un-
able to replicate in the presence of the latter
plasmids containing three and four pMB1 RNA I
genes. Transcription of RNA I from these plas-
mid genes is probably sufficient to maintain an
RNA I level above the "critical" concentration
for full inhibition of plasmid DNA synthesis
from the pMB1 replicon.
Although it now seems clear from our work
and the work of others that inhibition of plasmid
DNA replication by RNA I is an important part
of the mechanism for regulating plasmid copy
number, there is evidence that other plasmid-
encoded elements may be involved in copy
control. Twigg and Sherratt (27) have shown
that deletion of a nonessential region of ColEl
gives a derivative with an elevated copy num-
ber. The deletion mutation is complementable
by a product encoded by the HaeII-C restriction
fragment of ColEl. Cesareni et al. (2) have
recently identified a gene within this fragment
which encodes a 63-amino-acid polypeptide
which they have designated rop (for repressor of
primer). They proposed that the product of this
gene regulates plasmid replication by repressing
the transcription of the primer for DNA synthe-
sis. Unlike RNA I, this product does not appear
to be involved in determining plasmid incom-
patibility.
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